Below are the most recent publications written about "Mycosis Fungoides" by people in Profiles.
-
Flerova E, Alpdogan O, Bhatti S, Nikbakht N, Wang ZX, Gong JZ. Anaplastic Large Cell Transformation of Mycosis Fungoides: Case Report and Review of the Literature. Am J Dermatopathol. 2023 Sep 01; 45(9):e74-e82.
-
Gleason L, Nikbakht N. Prognostic Relevance of Dominant Blood T-Cell Clones in Early Mycosis Fungoides. JAMA Dermatol. 2023 Jan 01; 159(1):116.
-
Beksaç B, Gleason L, Baik S, Ringe JM, Porcu P, Nikbakht N. Dermal fibroblasts promote cancer cell proliferation and exhibit fibronectin overexpression in early mycosis fungoides. J Dermatol Sci. 2022 Apr; 106(1):53-60.
-
Porcu P, Nikbakht N. New insights on treatment utilization and outcomes in early-stage mycosis fungoides. Br J Dermatol. 2021 04; 184(4):594-595.
-
Hossain C, Jennings T, Duffy R, Knoblauch K, Gochoco A, Chervoneva I, Shi W, Alpdogan SO, Porcu P, Pro B, Sahu J. The histological prevalence and clinical implications of folliculotropism and syringotropism in mycosis fungoides. Chin Clin Oncol. 2019 Feb; 8(1):6.
-
Andreozzi JM, Bru?a P, Tendler II, Mooney KE, Jarvis LA, Cammin J, Li H, Pogue BW, Gladstone DJ. Improving treatment geometries in total skin electron therapy: Experimental investigation of linac angles and floor scatter dose contributions using Cherenkov imaging. Med Phys. 2018 Jun; 45(6):2639-2646.
-
Martinez-Escala ME, Kantor RW, Cices A, Zhou XA, Kaplan JB, Pro B, Choi J, Guitart J. CD8+ mycosis fungoides: A low-grade lymphoproliferative disorder. J Am Acad Dermatol. 2017 Sep; 77(3):489-496.
-
Kann BH, Park HS, Yeboa DN, Aneja S, Girardi M, Foss FM, Roberts KB, Wilson LD. Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary Syndrome. Clin Lymphoma Myeloma Leuk. 2017 08; 17(8):520-526.e2.
-
Lesokhin AM, Ansell SM, Armand P, Scott EC, Halwani A, Gutierrez M, Millenson MM, Cohen AD, Schuster SJ, Lebovic D, Dhodapkar M, Avigan D, Chapuy B, Ligon AH, Freeman GJ, Rodig SJ, Cattry D, Zhu L, Grosso JF, Bradley Garelik MB, Shipp MA, Borrello I, Timmerman J. Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study. J Clin Oncol. 2016 08 10; 34(23):2698-704.
-
Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, Stadler R, Wood GS, Beylot-Barry M, Pham-Ledard A, Foss F, Girardi M, Bagot M, Michel L, Battistella M, Guitart J, Kuzel TM, Martinez-Escala ME, Estrach T, Papadavid E, Antoniou C, Rigopoulos D, Nikolaou V, Sugaya M, Miyagaki T, Gniadecki R, Sanches JA, Cury-Martins J, Miyashiro D, Servitje O, Muniesa C, Berti E, Onida F, Corti L, Hodak E, Amitay-Laish I, Ortiz-Romero PL, Rodríguez-Peralto JL, Knobler R, Porkert S, Bauer W, Pimpinelli N, Grandi V, Cowan R, Rook A, Kim E, Pileri A, Patrizi A, Pujol RM, Wong H, Tyler K, Stranzenbach R, Querfeld C, Fava P, Maule M, Willemze R, Evison F, Morris S, Twigger R, Talpur R, Kim J, Ognibene G, Li S, Tavallaee M, Hoppe RT, Duvic M, Whittaker SJ, Kim YH. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model. J Clin Oncol. 2015 Nov 10; 33(32):3766-73.